<DOC>
	<DOCNO>NCT00689351</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability immunogenicity 13-valent pneumococcal conjugate vaccine ( 13vPnC ) , relative 7-valent pneumococcal conjugate vaccine ( 7vPnC ) give concomitantly routine vaccine Korea .</brief_summary>
	<brief_title>Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2montholdinfants ( 42 98 day ) Available entire study period ( 14 month ) Previous vaccine pneumococcal , diptheria , tetanus , pertussis , polio Hib vaccine A previous severe reaction vaccine vaccinerelated component</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Prevention</keyword>
	<keyword />
	<keyword>pneumococcal</keyword>
	<keyword>disease</keyword>
	<keyword>Vaccine</keyword>
</DOC>